Skip to content
Coral Genomics logo

Coral Genomics

Coral Genomics is a YC Summer 2018 (S18) company. Based in San Francisco, CA, USA. Team of 5.

  • Genomics

About Coral Genomics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Coral Genomics develops clinical laboratory tests that predict which treatments will work best for individual autoimmune disease patients. The tests combine molecular, functional, and clinical data to guide treatment decisions, replacing trial-and-error prescribing. The company also targets a distinct patient subpopulation that does not respond to existing autoimmune therapies, an area current diagnostics and treatments do not address.

From the Y Combinator listing

How Coral Genomics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

New clinical tests for managing autoimmune treatments.

Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
San Francisco, CA, USA
Team size
5
Status
Acquired
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works